Meduslabs — Evidence-based health research
HomeCholesterolCholesterol Norm
In brief

LDL cholesterol norm

LDL is the bad cholesterol. LDL cholesterol must meet its norm above all, because it is the main factor helping your doctor work out how likely it is that you will have a significant cardiovascular event within the next 10 years. Based on that likelihood, you will be prescribed medication — or not [1].

Important: the norms are given in mmol/L. If your blood-test results are in mg/dL, you will find your cholesterol norm here.

According to your risk group, choose the norm you need to meet.

Triglycerides should be < 1.7 mmol/L. If the test is taken after eating, triglycerides should be < 2.3 mmol/L.

HDL cholesterol norm

HDL cholesterol has a norm too, but this time the situation is different, because HDL is the good cholesterol. Good cholesterol helps lower the bad, so you want it to be as high as possible — that way you reduce the earlier-mentioned likelihood of a significant cardiovascular event within the next 10 years. HDL cholesterol should be higher than its norm of 1.0 mmol/L, though it would be far better if your HDL cholesterol exceeded 1.5 mmol/L.

Interesting! If HDL cholesterol exceeds 2.3 mmol/L, then on the contrary — it may indicate a raised likelihood of mortality of any kind, and scientists have not yet worked out why [2].

Total cholesterol norm

Total cholesterol and its norm are not as important as the bad cholesterol. The norm for total cholesterol is < 4.9 mmol/L, but, as mentioned, you need to watch your LDL cholesterol and see to how to lower the bad cholesterol — then total cholesterol and its norm will no longer trouble you [3].

Cholesterol norm in mg/dL

You will find the full table of what the cholesterol norm should be in mg/dL here. Or you can convert mmol/L ↔ mg/dL yourself.

IMPORTANT. The formula below applies only to cholesterol (not to triglycerides).

Cholesterol and the norm for women

The LDL norm does not differ for women or men. LDL cholesterol in women must meet the norm < 3.0 mmol/L. If there are other risk factors, see the exact norm above, in the LDL norm section. HDL cholesterol in women must meet the norm > 1.2 mmol/L, though it is best to be > 1.5 mmol/L. Why does the cholesterol norm for women differ?

Cholesterol and the norm for men

LDL cholesterol in men should be < 3.0 mmol/L. If other conditions trouble you as well, you will find the exact figure in the section above, LDL norm. HDL cholesterol in men should be > 1.0 mmol/L — that is the bare minimum; the higher the number, the better.

What lowers cholesterol in the blood, so the norm is good?

There are natural solutions for how to put the HDL and LDL cholesterol norm in order. Strong extracts of certain medicinal-mushroom polysaccharides can lower the bad cholesterol, raise the good, and so balance their overall ratio to meet the norm. Which are the best, you will find out by clicking below.

To achieve cholesterol-lowering results, it is very important to use the highest-quality, strong and reliable products. The recommended formula for cholesterol control is AURI 25 from Zenius Labs™.

Related supplement
AURI 25 by Zenius Labs™ →

Frequently Asked Questions

What is the normal cholesterol level?

Total cholesterol should be below 5.0 mmol/L. LDL (the “bad”) — below 3.0 mmol/L, and HDL (the “good”) — above 1.0 mmol/L for men and 1.2 mmol/L for women. These limits are a guide and may differ according to age and risk factors.

Can cholesterol be lowered to the norm naturally?

Yes. For many people it is enough to adjust the diet, increase physical activity and take quality mushroom-polysaccharide supplements. It is important to choose not simple powders but a concentrated multi-extract formula, such as AURI 25 from Zenius Labs™.

What is the difference between LDL and HDL cholesterol?

LDL (low-density lipoprotein) carries cholesterol to the tissues, where it can build up in the walls of blood vessels. HDL (high-density lipoprotein) works in the opposite direction — it collects excess cholesterol and returns it to the liver to be removed. That is why it matters not only to lower LDL but also to raise HDL.

How often should cholesterol be checked?

Healthy adults are advised to check at least once every 5 years, and after the age of 40 or with risk factors — every year. If cholesterol is already raised — every 3 to 6 months.

Does high cholesterol cause symptoms?

No. Raised cholesterol usually causes no symptoms at all, which is why it is often called the “silent killer.” The only way to know your cholesterol level is a blood test.

References
  1. Research reference — academic.oup.com. Source
  2. Research reference — academic.oup.com. Source
  3. PubMed 28419274. PubMed
  4. PubMed 10856769. PubMed
  5. Yoon SJ et al. The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin. Thrombosis research . 2003. PubMed
  6. Bian C et al. A Novel Polysaccharide from AuriculariaAuricula Alleviates Thrombosis Induced by Carrageenan in Mice. Molecules (Basel, Switzerland) . 2022. PubMed
  7. Shi Q et al. Isolation, Characterization, and Antioxidant Activity of Melanin from Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms . 2023. PubMed
  8. Yin CM et al. Physicochemical Properties and Antioxidant Activity of Natural Melanin Extracted from the Wild Wood Ear Mushroom, Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms . 2022. PubMed
  9. Liu X et al. Comprehensive utilization of edible mushroom Auricularia auricula waste residue-Extraction, physicochemical properties of melanin and its antioxidant activity. Food science & nutrition . 2019. PubMed
  10. González-Bonilla A et al. Dietary Supplementation with Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Reduces Visceral Fat and Hyperlipidemia in Inhabitants of a Rural Community in Mexico. International journal of medicinal mushrooms . 2022. PubMed
  11. Abrams DI et al. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC complementary and alternative medicine . 2011. PubMed
  12. Belobrajdic DP et al. β-Glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp. Food & function . 2024. PubMed
  13. Maheshwari G et al. Characterization of the Nutritional Composition of a Biotechnologically Produced Oyster Mushroom and its Physiological Effects in Obese Zucker Rats. Molecular nutrition & food research . 2020. PubMed
  14. Sato M et al. Long-term intake of Tamogi-take mushroom (Pleurotus cornucopiae) mitigates age-related cardiovascular dysfunction and extends healthy life expectancy. npj aging . 2025. PubMed
  15. Gong J et al. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. Molecular nutrition & food research . 2018. PubMed
  16. Chen JT et al. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy . 2005. PubMed
  17. Millán J et al. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis . 2016. PubMed
  18. Singh DK et al. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. The Journal of pharmacology and experimental therapeutics . 2006. PubMed
  19. Castaño G et al. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clinical drug investigation . 2003. PubMed
  20. Xiong Z et al. An overview of the bioactivity of monacolin K / lovastatin. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association . 2019. PubMed
  21. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) et al. Scientific Opinion on additional scientific data related to the safety of monacolins from red yeast rice submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006. EFSA journal. European Food Safety Authority . 2025. PubMed
  22. Peng D et al. Original Research: The Effects of Red Yeast Rice Supplementation on Cholesterol Levels in Adults. The American journal of nursing . 2017. PubMed
  23. Gerards MC et al. Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis. Atherosclerosis . 2015. PubMed
  24. Cicero AFG et al. Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review. Nutrients . 2023. PubMed
  25. Buzzelli L et al. Alternative lipid lowering strategies: State-of-the-art review of red yeast rice. Fitoterapia . 2024. PubMed
  26. Hermans MP et al. The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea) and red yeast rice (Monascus purpureus) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia. Frontiers in pharmacology . 2023. PubMed
  27. Sun HJ et al. Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice. Cardiovascular diabetology . 2024. PubMed
  28. Park C et al. Disturbed flow induces reprogramming of endothelial cells to immune-like and foam cells under hypercholesterolaemia during atherogenesis. Cardiovascular research . 2025. PubMed
  29. Zhang S et al. Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytotherapy research : PTR . 2021. PubMed
  30. Wang J et al. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice. Journal of the American Heart Association . 2017. PubMed